The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALB.L Regulatory News (ALB)

  • There is currently no data for ALB

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 8 - Bionex Investments

9 Mar 2005 16:14

W.H. Ireland Limited9 March 2005 Date of Disclosure 9TH MARCH 2005 DISCLOSURE UNDER RULES 8.1(a), 8.1(b)(i) and 8.3 OF THE CITY CODE ON TAKEOVERS AND MERGERS Date of dealing 8TH MARCH 2005 Dealing in BIONEX INVESTMENTS PLC (name of company) 1) Class of securities (eg ordinary shares) ORDINARY 0.01P 2) Amount bought Amount sold Price per unit 750,000 1.6P 3) Resultant total of the same class owned or controlled (and percentage of class) 24,316,667 (15.4%) 4) Party making disclosure W H IRELAND LIMITED 5) EITHER (a) Name of purchaser/vendor (Note 1) MRS S VANDYK OR (b) if dealing for discretionary client(s), name of fund management organisation 6) Reason for disclosure (Note 2) (a) associate of (i) offeror (Note 3) NO (ii) offeree company NO Specify which category or categories of associate (1-8 overleaf) If category (8), explain (b) Rule 8.3 (ie disclosure because of ownership or control of 1% or more of the class of relevant securities dealt in) YES Signed, for and on behalf of the party named in (4) above N/A (Also print name of signatory) J F MOLYNEUX Telephone and extension number 020 7397 3065 Note 1. Specify owner, not nominee or vehicle company. If relevant, also identify controller of owner, eg where an owner normally acts on instructions of a controller Note 2. Disclosure might be made for more than one reason; if so, state all reasons. Note 3. Specify which offeror if there is more than one. Note 4. When an arrangement exists with any offeror, with the offeree company or which an associate of any offeror or of the offeree company in relation to relevant securities, details of such arrangement must be disclosed, as required by Note 6 on Rule 8 Note 5. It may be necessary, particularly when disclosing derivative transactions, to append a sheet to this disclosure form so that relevant information can be given. Note 6. In the case of an average price bargain, each underlying trade should be disclosed. Note 7. The resultant total percentage holding of the class of relevant security is to be calculated by reference to the percentage held and in issue outside treasury. For full details of disclosure requirements, see Rule 8 of the Code. If in doubt, contact the Panel on Takeovers and Mergers, Monitoring Section, Tel. No:020 7638 0129. Email: monitoring@disclosure.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
28th Aug 20194:41 pmRNSSecond Price Monitoring Extn
28th Aug 20194:35 pmRNSPrice Monitoring Extension
28th Aug 20197:00 amRNSSecondary Trading following Cancellation
23rd Aug 20195:30 pmRNSAlbert Technologies
23rd Aug 201911:00 amRNSPrice Monitoring Extension
20th Aug 20192:05 pmRNSSecond Price Monitoring Extn
20th Aug 20192:00 pmRNSPrice Monitoring Extension
20th Aug 201910:30 amRNSResult of EGM and Cancellation
8th Aug 201911:06 amRNSSecond Price Monitoring Extn
8th Aug 201911:00 amRNSPrice Monitoring Extension
30th Jul 20192:30 pmRNSCorrection:Proposed Cancellation of trading on AIM
25th Jul 20194:38 pmRNSHolding(s) in Company
16th Jul 20197:00 amRNSProposed Cancellation of trading on AIM
24th Jun 20197:00 amRNSAnnual Financial Report
28th May 20194:41 pmRNSSecond Price Monitoring Extn
28th May 20194:36 pmRNSPrice Monitoring Extension
28th May 20197:00 amRNSUpdate on Trading
17th May 20197:00 amRNSExercise of Options
18th Apr 20197:00 amRNSExercise of Options and AIM Rule 17 Update
10th Apr 20191:09 pmRNSHolding(s) in Company
9th Apr 20198:18 amRNSHolding(s) in Company
26th Mar 20197:00 amRNSFinal Results
22nd Jan 20197:00 amRNSTrading Statement
10th Jan 201911:19 amRNSHolding(s) in Company
5th Dec 201810:43 amRNSResults of EGM
29th Nov 20183:47 pmRNSPDMR Shareholding
13th Nov 20187:00 amRNSNotice of EGM
29th Oct 201810:23 amRNSGrant of Options
23rd Oct 201812:00 pmRNSAlbert in Gartner's 2018 Magic Quadrant - Ad Tech
23rd Oct 20187:00 amRNSExercise of Options / Additional Listing
22nd Oct 20184:35 pmRNSPrice Monitoring Extension
22nd Oct 20182:10 pmRNSHolding(s) in Company
22nd Oct 20182:10 pmRNSHolding(s) in Company
27th Sep 20181:26 pmRNSPDMR Shareholding
26th Sep 201811:14 amRNSDirector/PCA Shareholding
24th Sep 20187:00 amRNSInterim Results
6th Sep 20182:57 pmRNSResult of AGM
31st Jul 20187:00 amRNSTrading Update, Board Changes & Notice of AGM
28th Jun 20187:00 amRNSHolding(s) in Company
27th Jun 20185:59 pmRNSPosting of Annual Report
27th Jun 20187:00 amRNSTR-1: Notification of major holdings
25th Jun 20182:51 pmRNSExercise of Options
22nd Jun 201811:03 amRNSResult of General Meeting
31st May 20181:15 pmRNSResult of Conditional Placing and Notice of GM
31st May 20187:01 amRNSProspective Directorate Change
31st May 20187:00 amRNSProposed conditional placing
15th May 20182:18 pmRNSExercise of Options
30th Apr 20187:00 amRNSAlbert Names Rob Norman as Advisory Board Member
24th Apr 20187:00 amRNSSignificant Pilot Projects
11th Apr 20187:00 amRNSChange of Nominated Advisor and Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.